CDH1 and breast cancer: E-cadherin (E-cad, CDH1), commonly used as an epithelial state marker and thought to be a suppressor of tumor invasion, has been recently implicated in multiple breast cancer models, demonstrating its essential role in detachment, systemic dissemination, and seeding phases of metastasis by limiting reactive oxygen-mediated apoptosis [54].